We also assessed the therapeutic efficacy of dual proteasome and WEE kinase inhibition on the development of autochthonous liver cancers in immunocompetent mice, which were hydrodynamically injected with plasmids expressing myr-AKT and NRasG12V or c-Myc and sgTP53. The gene discussed is MYC; the disease is liver cancer.